This study is currently not recruiting participants.

The INFORM Study Follow-up

Investigating Tailored Messages for Risk of Abnormal Growths in the Colon or Rectum

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The primary aim of this study is to measure the effect of providing patients and their providers with tailored messages about the patient?s current risk of having an advanced colorectal neoplasm.

Detailed description of study

The primary aim of this study is to measure the effect of providing patients and their providers with tailored messages about the patient?s current risk of having an advanced colorectal neoplasm.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: colorectal cancer
  • Age: 100 years or below
  • Gender: All

The purpose of this study is to investigate how tailored messages can affect patients and their healthcare providers' understanding of the patient's risk of having an advanced colorectal neoplasm. Colorectal neoplasms are abnormal growths in the colon or rectum that can potentially lead to cancer if not detected and treated early.

Participants in the study will receive personalized messages that detail their current risk level for advanced colorectal neoplasms. These messages are designed to help both the patient and their healthcare provider better understand the patient's health status and make informed decisions about their care.

  • Who can participate: Eligibility criteria are not specified in the provided information.
  • Study details: Participants will receive tailored messages about their risk of advanced colorectal neoplasms, aimed at informing both the patient and their healthcare provider.
Updated on 19 Feb 2024. Study ID: 1711043202

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team